Early alzheimer's and parkinson's disease pathology in urban children: Friend versus foe responses - It is time to face the evidence

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Calderón Garcidueñas, Lilian ^a   Franco Lira, Maricela ^b   Mora Tiscareño, Antonieta ^c   Medina Cortina, Humberto ^c   Torres Jardón, Ricardo ^d   Kavanaugh, Michael ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b HOSPITAL CENTRAL MILITAR   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN; AMYLOID BETA PROTEIN;

AIR POLLUTION; ALZHEIMER DISEASE; BLOOD VESSEL INJURY; BRAIN STEM; CHILD; COGNITION; DEGENERATIVE DISEASE; DNA POLYMORPHISM; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; FRONTAL CORTEX; GENOTYPE; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; OLFACTORY BULB; PARKINSON DISEASE; PARTICULATE MATTER; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; REVIEW; UNITED STATES; URBAN POPULATION; ADOLESCENT; ADULT; BRAIN; CITY; DRUG EFFECT; FEMALE; MALE; METABOLISM; MEXICO; ONSET AGE; OXIDATIVE STRESS;

ADOLESCENT; ADULT; AGE OF ONSET; AIR POLLUTION; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CHILD; CITIES; FEMALE; HUMANS; MALE; MEXICO; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICULATE MATTER; PROTEIN FOLDING; TAU PROTEINS; URBAN POPULATION; YOUNG ADULT;

EID: 84874618645     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/161687     Document Type: Review

References (129)

1. Molina L. T., Molina M. J., Improving air quality in megacities: Mexico City case study. Annals of the New York Academy of Sciences 2004 1023 142 158 2-s2.0-3242696811 10.1196/annals.1319.006 (Pubitemid 38951561)
2. Chen B., Kan H., Air pollution and population health: a global challenge. Environmental Health and Preventive Medicine 2008 13 2 94 101 2-s2.0-49549110897 10.1007/s12199-007-0018-5
3. Parrish D. D., Zhu T., Clean air for megacities. Science 2009 326 5953 674 675 2-s2.0-70350613919 10.1126/science.1176064
4. Bloom D. E., 7 Billion and counting. Science 2011 333 6042 562 569 2-s2.0-79960964536 10.1126/science.1209290
5. Rodrigues R., Smith M. A., Wang X., Perry G., Lee H. G., Zhu X., Petersen R. B., Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. Future Neurology 2012 7 287 305
6. Nunomura A., Moreira P. I., Castellani R. J., Lee H. G., Zhu X., Smith M. A., Perry G., Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotoxicity Research 2012 22 231 248
7. Hirsch E. C., Jenner P., Przedborski S., Pathogenesis of Parkinson's disease. Movement Disorders. In press 10.1002/mds.25032
8. Block M. L., Calderón-Garcidueñas L., Air pollution: mechanisms of neuroinflammation and CNS disease. Trends in Neurosciences 2009 32 9 506 516 2-s2.0-69949111672 10.1016/j.tins.2009.05.009
9. Oberdörster G., Elder A., Rinderknecht A., Nanoparticles and the brain: cause for concern? Journal of Nanoscience and Nanotechnology 2009 9 8 4996 5007 2-s2.0-70350357325 10.1166/jnn.2009.GR02
10. Brook R. D., Rajagopalan S., Pope C. A. III, American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010 121 2331 2378
11. Kampfrath T., Maiseyeu A., Ying Z., Shah Z., Deiuliis J. A., Xu X., Kherada N., Brook R. D., Reddy K. M., Padture N. P., Parthasarathy S., Chen L. C., Moffatt-Bruce S., Sun Q., Morawietz H., Rajagopalan S., Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circulation Research 2011 108 6 716 726 2-s2.0-79953058038 10.1161/CIRCRESAHA.110.237560
12. Molina L. T., Kolb C. E., de Foy B., Lamb B. K., Brune W. H., Jimenez J. L., Ramos-Villegas R., Sarmiento J., Paramo-Figueroa V. H., Cardenas B., Gutierrez-Avedoy V., Molina M. J., Air quality in North America's most populous city-overview of the MCMA-2003 campaign. Atmospheric Chemistry and Physics 2007 7 10 2447 2473 2-s2.0-34248586810 (Pubitemid 46751595)
13. Molina L. T., Madronich S., Gaffney J. S., Apel E., De Foy B., Fast J., Ferrare R., Herndon S., Jimenez J. L., Lamb B., Osornio-Vargas A. R., Russell P., Schauer J. J., Stevens P. S., Volkamer R., Zavala M., An overview of the MILAGRO 2006 Campaign: Mexico City emissions and their transport and transformation. Atmospheric Chemistry and Physics 2010 10 18 8697 8760 2-s2.0-76749092739 10.5194/acp-10-8697-2010
14. Evans J., Levy J., Hammitt J., Molina L. T., Molina M. J., Health benefits of air pollution control. Air Quality in the Mexico Megacity: An Integrated Assessment 2002 Kluwer Academic Publishers 103 136
15. Ezcurra E., Mazari-Hiriart M., Are megacities viable? A cautionary tale from Mexico City. Environment 1996 38 1 6 15 2-s2.0-0030054059 (Pubitemid 26040886)
16. Bravo-Alvarez H., Torres-Jardn R., Fenn M., de Bauer L., Hernández T., Air pollution levels and trends in the México City metropolitan area. Urban Air Pollution and Forest: Resources at Risk in the Mexico City Air Basin 2002 156 chapter 6 New York, NY, USA Springer 121 159 Ecological Studies
17. Osornio-Vargas A. R., Bonner J. C., Alfaro-Moreno E., Martínez L., García-Cuellar C., Ponce-de-León Rosales S., Miranda J., Rosas I., Proinflammatory and cytotoxic effects of Mexico City air pollution particulate matter in vtro are dependent on particle size and composition. Environmental Health Perspectives 2003 111 10 1289 1293 2-s2.0-0041973856 (Pubitemid 37021130)
18. 10 composition and cell toxicity: a multivariate and graphical approach. Chemosphere 2007 67 6 1218 1228 2-s2.0-33846631751 10.1016/j.chemosphere.2006. 10.078 (Pubitemid 46185528)
19. Querol X., Pey J., Minguilln M. C., PM speciation and sources in Mexico during the MILAGRO-2006 Campaign. Atmospheric Chemistry and Physics 2008 8 111 128
20. SMA-GDF (Secretaria del Medio Ambiente del Gobierno del Distrito Federal), Sistema de Monitoreo Atmosférico. Secretaría del Medio Ambiente. http://www.calidadaire.df.gob.mx/calidadaire/index.php
21. Tang T., Hurraß Gminski R., Mersch-Sundermann V., Fine and ultrafine particles emitted from laser printers as indoor air contaminants in German offices. Environmental Science and Pollution Research 2012 19 9 3840 3849 10.1007/s11356-011-0647-5
22. Fröhlich E., Roblegg E., Models for oral uptake of nanoparticles in consumer products. Toxicology 2012 291 1-3 10 17
23. Atkinson R. W., Carey I. M., Kent A. J., van Staa T. P., Anderson H. R., Cook D. G., Long-term exposure to outdoor air pollution and incidence of cardiovascular disease. Epidemiology 2013 24 44 53
24. Zhang Z. F., Yu S. Z., Zhou G. D., Indoor air pollution of coal fumes as a risk factor of stroke, Shanghai. American Journal of Public Health 1988 78 8 975 977 2-s2.0-0023807246
25. Villeneuve P. J., Johnson J. Y., Pasichnvk D., Lowes J., Kirkland S., Rowe B. H., Short-term effects of ambient air pollution on stroke: who is most vulnerable? Science of the Total Environment 2012 430 193 201
26. Calderón-Garcidueňas L., Vincent R., Mora-Tiscareňo A., Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution. Environmental Health Perspectives 2007 115 1248 1253 (Pubitemid 351802360)
27. Calderón-Garcidueñas L., Mora-Tiscareño A., Fordham L. A., Valencia-Salazar G., Chung C. J., Rodriguez-Alcaraz A., Paredes R., Variakojis D., Villarreal-Calderón A., Flores-Camacho L., Antunez-Solis A., Henríquez-Roldán C., Hazucha M. J., Respiratory damage in children exposed to urban pollution. Pediatric Pulmonology 2003 36 2 148 161 2-s2.0-0041695205 10.1002/ppul.10338 (Pubitemid 36966061)
28. Calderón-Garcidueñas L., Macias-Parra M., Hoffmann H. J., Immunotoxicity and environment: immunodysregulation and systemic inflammation in children. Toxicologic Pathology 2009 37 161 169
29. Calderón-Garcidueñas L., Mora-Tiscareňo A., Ontiveros E., Air pollution, cognitive deficits and brain abnormalities: a pilot study with children and dogs. Brain and Cognition 2008 68 117 127
30. Calderón-Garcidueñas L., Kavanaugh M., Block M. L., Neuroinflammation, hyperphosphorilated tau, diffuse amyloid plaques and down- regulation of the cellular prion protein in air pollution exposed children and adults. Journal of Alzheimer Disease 2012 28 93 107
31. Calderón-Garcidueñas L., Serrano-Sierra A., Torres-Jardón R., The impact of environmental metals in young urbanites' brains. Experimental and Toxicologic Pathology. In press
32. Calderón-Garcidueñas L., Mora-Tiscareón A., Styner M., White matter hyperintensities, systemic inflammation, brain growth and cognitive functions in children exposed to air pollution. Journal of Alzheimer's Disease 2012 31 1 183 191
33. Calderón-Garcidueñas L., Torres-Jardón R., Air pollution, socioeconomic status and children's cognition in megacities: the Mexico City Scenario. Frontiers in Psychology 2012 3, article 217
34. Rivest S., Lacroix S., Vallières L., Nadeau S., Zhang J., Laflamme N., How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proceedings of the Society for Experimental Biology and Medicine 2000 223 1 22 38 2-s2.0-0034105064 (Pubitemid 30182654)
35. Calderón-Garcidueñas L., Solt A. C., Henríquez- Roldán C., Torres-Jardón R., Nuse B., Herritt L., Villarreal-Calderón R., Osnaya N., Stone I., García R., Brooks D. M., González-Maciel A., Reynoso-Robles R., Delgado-Chávez R., Reed W., Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid β -42 and α -synuclein in children and young adults. Toxicologic Pathology 2008 36 2 289 310 2-s2.0-42149103828 10.1177/0192623307313011 (Pubitemid 351534490)
36. Saunders N. R., Liddelow S. A., Dziegielewska K. M., Barrier mechanisms in the developing brain. Frontiers in Psychology 2012 3, article 46
37. Heumann D., Roger T., Initial responses to endotoxins and Gram-negative bacteria. Clinica Chimica Acta 2002 323 1-2 59 72 2-s2.0-0036065342 10.1016/S0009-8981(02)00180-8 (Pubitemid 34804795)
38. Bonner J. C., Rice A. B., Lindroos P. M., O'Brien P. O., Dreher K. L., Rosas I., Alfaro-Moreno E., Osornio-Vargas A. R., Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City. American Journal of Respiratory Cell and Molecular Biology 1998 19 4 672 680 2-s2.0-0032185780 (Pubitemid 128354250)
39. Yang E. J., Kim S., Kim J. S., Choi J. H., Inflammasome formation and IL1 β release by human blood monocytes in response to silver nanoparticles. Biomaterials 2012 33 6858 6867
40. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J., T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009 460 7252 269 273 2-s2.0-67650421494 10.1038/nature08100
41. Dostert C., Pétrilli V., van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 320 5876 674 677 2-s2.0-43249125839 10.1126/science.1156995 (Pubitemid 351928351)
42. Morris M., Li L., Molecular mechanisms and pathological consequences of endotoxin tolerance and priming. Archivum Immunologiae Et Therapiae Experimentalis 2012 60 13 18
43. Villarreal-Calderón R., Dale G., Delgado-Chavez R., Intra-city differences in cardiac expression of inflammatory genes and inflammasomes in young urbanites: a pilot study. Journal of Toxicologic Pathology 2012 25 163 173
44. Calderón-Garcidueñas L., Engle R., Mora-Tiscareño A., Exposure to severe urban pollution influences cognitive outcomes, brain volume and systemic inflammation in clinically healthy children. Brain Cognition 2011 77 345 355
45. Calderón-Garcidueñas L., Azzarelli B., Acuña H., Air pollution and brain damage. Toxicologic Pathology 2002 30 373 389 (Pubitemid 34556108)
46. Calderón-Garcidueñas L., Maronpot R. R., Torres-Jardon R., Henríquez-Roldán C., Schoonhoven R., Acuña-Ayala H., DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicologic Pathology 2003 31 524 538 (Pubitemid 37151425)
47. Chambers J. K., Mutsuga M., Uchida K., Nakayama H., Characterization of A β pN3 deposition in the brains of dogs of various ages and other animal species. Amyloid 2011 18 2 63 71 2-s2.0-79955801619 10.3109/13506129.2011.570385
48. Yu C. H., Song G. S., Yhee J. Y., Kim J. H., Im K. S., Nho W. G., Lee J. H., Sur J. H., Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction. Journal of Comparative Pathology 2011 145 1 45 58 2-s2.0-79956035555 10.1016/j.jcpa.2010.11.004
49. Cotman C. W., Head E., The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. Journal of Alzheimer's Disease 2008 15 4 685 707 2-s2.0-58149380028
50. Campbell A., Araujo J. A., Li H., Sioutas C., Kleinman M., Particulate matter induced enhancement of inflammatory markers in the brains of apolipoprotein E knockout mice. Journal of Nanoscience and Nanotechnology 2009 9 8 5099 5104 2-s2.0-68249139284
51. Levesque S., Surace M. J., McDonald J., Block M. L., Air pollution and the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease. Journal of Neuroinflammation 2011 8, article 105
52. Levesque S., Taetzsch T., Lull M. E., Diesel exhaust activates and primes microglia: air pollution, neuroinflammation and regulation of dopaminergic neurotoxicity. Environmental Health Perspectives 2011 119 1149 1155
53. Rivest S., Regulation of innate immune responses in the brain. Nature Reviews Immunology 2009 9 6 429 439 2-s2.0-66449130960 10.1038/nri2565
54. Simard A. R., Rivest S., Role of inflammation in the neurobiology of stem cells. NeuroReport 2004 15 15 2305 2310 2-s2.0-8444231250 10.1097/00001756- 200410250-00001 (Pubitemid 39488909)
55. Fassbender K., Walter S., Kühl S., Landmann R., Ishii K., Bertsch T., Stalder A. K., Muehlhauser F., Liu Y., Ulmer A. J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., Beyreuther K., The LPS receptor (CD14) links innate immunity with Alzheimer's disease. The FASEB Journal 2004 18 1 203 205 2-s2.0-1342332161
56. Nguyen M. D., Julien J. P., Rivest S., Innate immunity: the missing link in neuroprotection and neurodegeneration? Nature Reviews Neuroscience 2002 3 3 216 227 2-s2.0-0036518997 10.1038/nrn752 (Pubitemid 135706591)
57. Kim W. K., Alvarez X., Fisher J., Bronfin B., Westmoreland S., McLaurin J., Williams K., CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. American Journal of Pathology 2006 168 3 822 834 2-s2.0-33644657843 10.2353/ajpath.2006.050215 (Pubitemid 43327735)
58. Wu J., Wang C., Sun J., Xue Y., Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011 5 6 4476 4489 2-s2.0-79959790434 10.1021/nn103530b
59. Sharma H. S., Sharma A., Neurotoxicity of engineered nanoparticles from metals. CNS & Neurological Disorders 2012 11 65 80
60. Trickler W. J., Lantz S. M., Schrand A. M., Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine 2012 7 835 846
61. Win-Shwe T. T., Fujimaki H., Nanoparticles and neurotoxicity. International Journal of Molecular Sciences 2011 12 6267 6280
62. Ho Y. S., Yang X., Yeung S. C., Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats. PLoS One 2012 7 5 e36752
63. Lucchini R. G., Dorman D. C., Elder A., Veronesi B., Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology 2012 33 838 841
64. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J., Crews F. T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. GLIA 2007 55 5 453 462 2-s2.0-33847759064 10.1002/glia.20467 (Pubitemid 46383175)
65. Hartz A. M. S., Bauer B., Block M. L., Hong J. S., Miller D. S., Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. The FASEB Journal 2008 22 8 2723 2733 2-s2.0-48749119557 10.1096/fj.08-106997
66. MohanKumar S. M., Campbell A., Block M., Veronesi B., Particulate matter, oxidative stress and neurotoxicity. Neurotoxicology 2008 29 3 479 488 2-s2.0-49949096489 10.1016/j.neuro.2007.12.004
67. Calderón-Garcidueñas L., D'Angiulli A., Kulesza R. J., Torres-Jardón R., Osnaya N., Romero L., Keefe S., Herritt L., Brooks D. M., Avila-Ramirez J., Delgado-Chávez R., Medina-Cortina H., González-González L. O., Air pollution is associated with brainstem auditory nuclei pathology and delayed brainstem auditory evoked potentials. International Journal of Developmental Neuroscience 2011 29 4 365 375 2-s2.0-79955786502 10.1016/j.ijdevneu.2011.03.007
68. Tjälve H., Henriksson J., Tallkvist J., Larsson B. S., Lindquist N. G., Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacology and Toxicology 1996 79 6 347 356 2-s2.0-0030444977 (Pubitemid 27008057)
69. Tjalve H., Henriksson J., Uptake of metals in the brain via olfactory pathways. NeuroToxicology 1999 20 2-3 181 195 2-s2.0-0033042991
70. Dorman D. C., Struve M. F., Marshall M. W., Parkinson C. U., James R. A., Wong B. A., Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicological Sciences 2006 92 1 201 210 2-s2.0-33745590402 10.1093/toxsci/kfj206 (Pubitemid 43985802)
71. Wang Y., Wang B., Zhu M. T., Li M., Wang H. J., Wang M., Ouyang H., Chai Z. F., Feng W. Y., Zhao Y. L., Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicology Letters 2011 205 1 26 37 2-s2.0-79959925771 10.1016/j.toxlet.2011.05. 001
72. Doty R. L., Symposium overview: do environmental agents enter the brain via the olfactory mucosa to induce neurodegenerative diseases. Annals of the New York Academy of Sciences 2009 1170 610 614 2-s2.0-68649123827 10.1111/j.1749-6632.2009.03926.x
73. Doty R. L., Olfactory dysfunction in Parkinson's disease. Nature Reviews Neurology 2012 8 329 339
74. Doty R. L., Olfaction in Parkinson's disease and related disorders. Neurobiology of Disease 2012 46 527 552
75. Schofield P. W., Ebrahimi H., Jones A. L., Bateman G. A., Murray S. R., An olfactory "stress test" may detect preclinical Alzheimer's disease. BMC Neurology 2012 12, article 24
76. Rahayel S., Frasnelli J., Joubert S., The effects of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis. Brain Research 2012 1442 55 65
77. Calderón-Garcidueñas L., Franco-Lira M., Henríquez-Roldán C., Osnaya N., González-Maciel A., Reynoso-Robles R., Villarreal-Calderon R., Herritt L., Brooks D., Keefe S., Palacios-Moreno J., Villarreal-Calderon R., Torres-Jardón R., Medina-Cortina H., Delgado-Chávez R., Aiello-Mora M., Maronpot R. R., Doty R. L., Urban air pollution: influences on olfactory function and pathology in exposed children and young adults. Experimental and Toxicologic Pathology 2010 62 1 91 102 2-s2.0-71849109449 10.1016/j.etp.2009.02.117
78. Holtzman D. M., Herz J., Bu G., Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012 2 3 a006312
79. Olivecrona Z., Koskinen L. O., The release of S-100B and NSE in severe traumatic head injury is associated with ApoE 4. Acta Neurochirurgica 2012 154 675 680
80. Chaudhary R., Likidlilid A., Peerapatdit T., Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovascular Diabetology 2012 11, article 36
81. Fernández-Irigoyen J., Corrales F. J., Santamaria E., Proteomic atlas of the human olfactory bulb. Journal of Proteomics 2012 75 13 4005 4016
82. Schroder K., Sagulenko V., Zamoshnikova A., Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology 2012 217 12 1325 1329
83. Lamkanfi M., Dixit V. M., Inflammasomes and their roles in health and disease. Annual Review of Cell and Developmental Biology 2012 28 137 161
84. Martinon F., Signaling by ROS drives inflammasome activation. European Journal of Immunology 2010 40 3 616 619 2-s2.0-77749304032 10.1002/eji.200940168
85. Hanamsagar R., Hanke M. L., Kielian T., Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends in Immunology 2012 33 333 342
86. Latz E., The inflammasomes: mechanisms of activation and function. Current Opinion in Immunology 2010 22 1 28 33 2-s2.0-77249118801 10.1016/j.coi.2009.12.004
87. Villarreal-Calderon R., Torres-Jardón R., Palacios-Moreno J., Osnaya N., Pérez-Guillé B., Maronpot R. R., Reed W., Zhu H., Calderón-Garcidueñas L., Urban air pollution targets the dorsal vagal complex and dark chocolate offers neuroprotection. International Journal of Toxicology 2010 29 6 604 615 2-s2.0-78650921191 10.1177/1091581810383587
88. Tabert M. H., Liu X., Doty R. L., Serby M., Zamora D., Pelton G. H., Marder K., Albers M. W., Stern Y., Devanand D. P., A 10-item smell identification scale related to risk for Alzheimer's disease. Annals of Neurology 2005 58 1 155 160 2-s2.0-21844469971 10.1002/ana.20533 (Pubitemid 40962473)
89. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
90. Braak H., Del Tredici K., Rüb U., de Vos R. A. I., Jansen Steur E. N. H., Braak E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003 24 2 197 211 2-s2.0-0037333666 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
91. Braak H., Rüb U., Gai W. P., Del Tredici K., Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 2003 110 5 517 536 2-s2.0-0038748401 10.1007/s00702-002-0808-2 (Pubitemid 36543283)
92. Braak H., Thal D. R., Ghebremedhin E., Del Tredici K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. Journal of Neuropathology & Experimental Neurology 2011 70 11 960 969
93. Braak H., Del Tredici K., The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathologica 2011 121 2 171 181 2-s2.0-79451471618 10.1007/s00401-010-0789-4
94. Jellinger K., Braak H., Braak E., Fischer P., Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Annals of the New York Academy of Sciences 1991 640 203 209 2-s2.0-0026378372
95. Jellinger K. A., Interaction between pathogenic proteins in neurodegenerative disorders. Journal of Cellular and Molecular Medicine 2012 16 1166 1183
96. Meissner W. G., When does Parkinson's disease begin? From prodromal disease to motor signs. Revue Neurologique 2012 168 11 809 814
97. Jefferson A. L., Massaro J. M., Wolf P. A., Inflammatory markers are associated with total brain volume: the Framingham Heart Study. Neurology 2007 68 1032 1038 (Pubitemid 46569138)
98. Jefferson A. L., Massaro J. M., Beiser A. S., Seshadri S., Larson M. G., Wolf P. A., Au R., Benjamin E. J., Inflammatory markers and neuropsychological functioning: the Framingham Heart Study. Neuroepidemiology 2011 37 1 21 30 2-s2.0-79960247200 10.1159/000328864
99. Bohnen N. I., Miiller M. L. T. M., Kuwabara H., Constantine G. M., Studenski S. A., Age-associated leukoaraiosis and cortical cholinergic deafferentation. Neurology 2009 72 16 1411 1416 2-s2.0-67449110909 10.1212/WNL.0b013e3181a187c6
100. Bohnen N. I., Albin R. L., White matter lesions in Parkinson disease. Nature Reviews Neurology 2011 7 4 229 236 2-s2.0-79953775516 10.1038/nrneurol.2011.21
101. Silbert L. C., Howieson D. B., Dodge H., Kaye J. A., Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009 73 2 120 125 2-s2.0-68149174856 10.1212/WNL.0b013e3181ad53fd
102. Brickman A. M., Zahra A., Muraskin J., Steffener J., Holland C. M., Habeck C., Borogovac A., Ramos M. A., Brown T. R., Asllani I., Stern Y., Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Research 2009 172 2 117 120 2-s2.0-63449089391 10.1016/j.pscychresns.2008.11.006
103. Murray M. E., Senjem M. L., Petersen R. C., Hollman J. H., Preboske G. M., Weigand S. D., Knopman D. S., Ferman T. J., Dickson D. W., Jack C. R., Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Archives of Neurology 2010 67 11 1379 1385 2-s2.0-78149485222 10.1001/archneurol.2010.280
104. Gouw A. A., Seewann A., van der Flier W. M., Barkhof F., Rozemuller A. M., Scheltens P., Geurts J. J. G., Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 2 126 135 2-s2.0-78751574080 10.1136/jnnp.2009.204685
105. Bunce D., Anstey K. J., Cherbuin N., Burns R., Christensen H., Wen W., Sachdev P. S., Cognitive deficits are associated with frontal and temporal lobe white matter lesions in middle-aged adults living in the community. PLoS ONE 2010 5 10 2-s2.0-78149426261 10.1371/journal.pone.0013567 e13567
106. Wallin A., Fladby T., Do white matter hyperintensities on MRI matter clinically? British Medical Journal 2010 341 c3400 2-s2.0-77955475934 10.1136/bmj.c3400
107. Maillard P., Fletcher E., Harvey D., Carmichael O., Reed B., Mungas D., Decarli C., White matter hyperintensity penumbra. Stroke 2011 42 7 1917 1922 2-s2.0-79960010842 10.1161/STROKEAHA.110.609768
108. Wang J. Z., Xia Y. Y., Grundke-Iqbal I., Iqbal K., Abnormal hyperphosphorylation of tau: sites, regulation and molecular mechanism of neurofibrillary degeneration. Journal of Alzheimer's Disease. In press
109. Avila J., León-Espinosa G., García E., Garcia-Escudero V., Hernández F., Defelipe J., Tau phosphorilation by GSK3 in different conditions. International Journal of Alzheimer's Disease 2012 2012 7 578373 10.1155/2012/578373
110. Bonda D. J., Castellani R. J., Zhu X., A novel perspective on Tau in Alzheimer's disease. Current Alzheimer Research 2011 8 6 639 642
111. Lee H. G., Perry G., Moreira P. I., Garrett M. R., Liu Q., Zhu X., Takeda A., Nunomura A., Smith M. A., Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends in Molecular Medicine 2005 11 4 164 169 2-s2.0-17044435830 10.1016/j.molmed.2005.02.008
112. De Calignon A., Fox L. M., Pitstick R., Carlson G. A., Bacskai B. J., Spires-Jones T. L., Hyman B. T., Caspase activation precedes and leads to tangles. Nature 2010 464 7292 1201 1204 2-s2.0-77951540816 10.1038/nature08890
113. Buée L., Troquier L., Burnouf S., Belarbi K., Van Der Jeugd A., Ahmed T., Fernandez-Gomez F., Caillierez R., Grosjean M. E., Begard S., Barbot B., Demeyer D., Obriot H., Brion I., Buée-Scherrer V., Maurage C. A., Balschun D., D'Hooge R., Hamdane M., Blum D., Sergeant N., From tau phosphorylation to tau aggregation: what about neuronal death? Biochemical Society Transactions 2010 38 4 967 972 2-s2.0-77955978487 10.1042/BST0380967
114. Avila J., Intracellular and extracellular tau. Frontiers in Neuroscience 2010 4, article 49
115. Hanger D. P., Wray S., Tau cleavage and tau aggregation in neurodegenerative disease. Biochemical Society Transactions 2010 38 4 1016 1020 2-s2.0-77955943958 10.1042/BST0381016
116. Cui B., Zhu L., She X., Chronic noise exposure causes persistence of tau hyperphosphorilation and formation of NFT tau in the rat hippocampus and prefrontal cortex. Experimental Neurology 2012 238 122 129
117. Lénárt N., Szegedi V., Juhász G., Increased Tau phosphorilation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice. PLOS ONE 2012 7 9 e46007
118. Lee C. W., Shih Y. S., Wu S. Y., Yang T., Lin C., Kuo Y. M., Hypoglycemia induces tau hyperphosphorilation. Current Alzheimer Research. In press
119. Cerf E., Gustot A., Goormaghtigh E., Ruysschaert J. M., Raussens V., High ability of apolipoprotein E4 to stabilize amyloid- β peptide oligomers, the pathological entities responsible for Alzheimer's disease. The FASEB Journal 2011 25 5 1585 1595 2-s2.0-79955663093 10.1096/fj.10-175976
120. Silva B. A., Breydo L., Fink A. L., Uversky V. N., Agrochemicals, α -synuclein and Parkinson's disease. Molecular Neurobiology. In press
121. Perfeito R., Cunha-Oliveira T., Rego A. C., Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson's disease-resemblance to the effect of amphetamine drugs of abuse. Free Radical Biology & Medicine 2012 53 1791 1806
122. Musgrove R. E., King A. E., Dickson T. C., a-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signaling pathway. Neurotoxicity Research. In press
123. Béraud D., Hathaway H. A., Trecki J., Microglial activation and antioxidant responses induced by the Parkinson's disease protein a-synuclein. Journal of NeuroImmune Pharmacology. In press
124. Stern Y., Cognitive reserve in aging and Alzheimer's disease. Lancet Neurology 2012 11 1006 1012
125. Jian H., Yi-Fang W., Qi L., Xiai-Song H., Gui-Yun Z., Cerebral blood flow and metabolic changes in hippocampal regions of a modified rat model with chronic cerebral hypoperfusion. Acta Neurologica Belgica. In press
126. Roher A. E., Debbins J. P., Malek-Ahmadi M., Cerebral blood flow in Alzheimer's disease. Journal of Vascular Health and Risk Management 2012 8 599 611
127. De la Torre J. C., A turning point for Alzheimer's disease? Biofactors 2012 38 78 83
128. Castellani R. J., Perry G., Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. Archives of Medical Research 2012 43 8 694 698
129. http://www.epa.gov/oaqps001/greenbk/